The blood glucose-lowering effect of racecadotril is not attributable to inhibition of insulin-degrading enzyme

S. Kurklinsky, S. O. Abdul-Hay, M. P. McGuire, E. A. Howard, J. Knight, M. A. Leissring

Research output: Contribution to journalLetter

Original languageEnglish
Pages (from-to)73-74
Number of pages2
JournalHormone and Metabolic Research
Volume46
Issue number1
DOIs
Publication statusPublished - 1 Jan 2014

Cite this